Geetha Manjunath: How NIRAMAI is Using AI to Make Breast Cancer Screening Accessible
A chance to rethink how breast cancer is detected became the starting point of a larger mission for Dr. Geetha Manjunath. With a career spanning supercomputing, artificial intelligence and data science, she turned her research expertise towards a healthcare challenge that affects millions of women.
Today, as the Founder and CEO of NIRAMAI Health Analytix, Geetha is using artificial intelligence to make breast cancer screening more accessible, comfortable and affordable.
Early Life and Educational Background
Geetha’s interest in technology started long before she became a researcher or entrepreneur. Growing up in Bengaluru, she was curious about how things worked. Her father encouraged that curiosity, often involving her in fixing household appliances and understanding the mechanics behind everyday objects. Those seemingly small experiences helped shape her problem-solving mindset.
She went on to study Computer Science at the University Visvesvaraya College of Engineering (UVCE). Her interest in research took her to the Indian Institute of Science (IISc), Bengaluru, where she pursued a master’s degree and a PhD in Artificial Intelligence and Data Mining. She also completed management education at the Kellogg School of Management in Chicago.
Her education gave her a strong foundation in technology, but it was her experiences outside the classroom that would eventually influence the direction of her career.
Professional Journey: From Supercomputers to AI Research
Geetha began her professional journey at the Centre for Development of Advanced Computing (C-DAC). She was part of the team involved in developing India’s first commercial supercomputer, an experience that introduced her to the possibilities of using technology to solve complex problems.
She went on to join Hewlett Packard labs as a Principal Research Scientist, where she worked for a few years in the domain of research and new technologies. She then moved to Xerox Research to lead research on data analytics and artificial intelligence.
Innovation and experimentation formed the core of her professional life. Nevertheless, Geetha felt that, even after all her contributions to technology, she needed to find an area in which her knowledge could benefit humanity directly.
The Personal Motivation Behind NIRAMAI
The turning point came when Geetha learned that two women in her extended family had been diagnosed with breast cancer at relatively young ages. Their experiences made her think more deeply about the difficulties women face when it comes to screening and early detection.
Her work started focusing on the shortcomings of traditional screening techniques and the factors preventing women from going for screening. Among the issues that were of interest to Geetha were those related to pain, risk of radiation and lack of screening facilities.
Next, Geetha turned her attention to whether artificial intelligence could be used to solve some of the problems associated with screening. She realized there was a possibility of bringing healthcare and technology closer to each other.
It was at this point that she decided to found NIRAMAI Health Analytix along with Nidhi Mathur. Their goal was to create a new method of screening for breast cancer using thermal imaging and artificial intelligence.
How NIRAMAI is Changing Breast Cancer Screening
NIRAMAI, short for Non-Invasive Risk Assessment with Machine Intelligence, developed Thermalytix, an AI-powered breast health screening solution.
This technology uses thermal imaging combined with machine learning algorithms to examine temperature patterns and differences in the tissue of breasts. These patterns help determine if there are any abnormalities and aid in determining if further testing is required.
One thing that sets this method apart is the fact that it doesn’t involve any physical contact, radiation, or compression of breasts. This can make the process easier on women that have doubts about traditional screening methods.
The other benefit that this technology offers is its portability, which allows this screening to be implemented even in communities that are far away from advanced medical equipment.
However, for Geetha, creating such an application was always about much more than developing another AI-based tool. The problem had to be solved, and women needed to feel comfortable during the whole screening process.
Awards and Recognition
Geetha’s work at the intersection of artificial intelligence and healthcare has received recognition from several organisations. She was named among Forbes India’s Top 20 Self-Made Women in 2020 and received the BIRAC WinER Award in 2018.
Her other recognitions include the CSI Gold Medal, the Accenture Vahini Innovator of the Year Award and BioSpectrum India’s Women Entrepreneur of the Year award.
An inventor with more than 50 US patents, Geetha is also a senior member of IEEE and a Fellow of the Indian National Academy of Engineering. NIRAMAI’s technology has received international recognition, including US FDA clearance for its screening system.
Looking Ahead: Making Healthcare More Accessible
The path taken by Geetha is intriguing not only for her transition from technology research to entrepreneurship but also due to the reason why she chose to do so. Using the knowledge that she had spent years cultivating, Geetha addressed an issue affecting women and their families across the globe.
Moreover, her contribution helps to realize that artificial intelligence within the healthcare industry should not only involve technical advancements and complex algorithms but rather the ways in which it can help the medical personnel and improve the experience of the patients.
Through NIRAMAI, Geetha is striving to ensure that in the future, there will be more convenient ways to conduct screening and early detection of breast cancer.
